Cargando…

Identification of myeloid cells in the human enthesis as the main source of local IL-23 production

OBJECTIVE: We investigated whether the normal human spinal enthesis contained resident myeloid cell populations, capable of producing pivotal proinflammatory cytokines including tumour necrosis factor (TNF) and interleukin (IL)-23 and determined whether these could be modified by PDE4 inhibition. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bridgewood, Charlie, Watad, Abdulla, Russell, Tobias, Palmer, Timothy M, Marzo-Ortega, Helena, Khan, Almas, Millner, Peter A, Dunsmuir, Robert, Rao, Abhay, Loughenbury, Peter, Wittmann, Miriam, Cuthbert, Richard J, McGonagle, Dennis G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Spondyloarthritis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585277/ https://www.ncbi.nlm.nih.gov/pubmed/31018959 http://dx.doi.org/10.1136/annrheumdis-2018-214944

Ejemplares similares

Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression
por: Cuthbert, Richard James, et al.
Publicado: (2019)

IL-17A and TNF Modulate Normal Human Spinal Entheseal Bone and Soft Tissue Mesenchymal Stem Cell Osteogenesis, Adipogenesis, and Stromal Function
por: Russell, Tobias, et al.
Publicado: (2021)

Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression
por: Watad, Abdulla, et al.
Publicado: (2020)

Characterization of Blood Mucosal‐Associated Invariant T Cells in Patients With Axial Spondyloarthritis and of Resident Mucosal‐Associated Invariant T Cells From the Axial Entheses of Non‐Axial Spondyloarthritis Control Patients
por: Rosine, Nicolas, et al.
Publicado: (2022)

SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights
por: Zhou, Qiao, et al.
Publicado: (2021)

The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man
por: Bridgewood, Charlie, et al.
Publicado: (2019)

Intestinal and enthesis innate immunity in early axial spondyloarthropathy
por: Sharif, Kassem, et al.
Publicado: (2020)

The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science
por: Watad, Abdulla, et al.
Publicado: (2018)

Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis
por: McGonagle, Dennis, et al.
Publicado: (2021)

Corrigendum to: Intestinal and enthesis innate immunity in early axial spondyloarthropathy
por: Sharif, Kassem, et al.
Publicado: (2020)

Enthesitis: Much More Than Focal Insertion Point Inflammation
por: Watad, Abdulla, et al.
Publicado: (2018)

Severe COVID-19 as a virus-independent immunothrombotic process – Authors' reply
por: McGonagle, Dennis, et al.
Publicado: (2022)

Cytokine “fine tuning” of enthesis tissue homeostasis as a pointer to spondyloarthritis pathogenesis with a focus on relevant TNF and IL-17 targeted therapies
por: Russell, Tobias, et al.
Publicado: (2021)

Sex-Based Medicine Meets Psoriatic Arthritis: Lessons Learned and to Learn
por: Bragazzi, Nicola Luigi, et al.
Publicado: (2022)

COVID-19: angiotensin II in development of lung immunothrombosis and vasculitis mimics – Author's reply
por: McGonagle, Dennis, et al.
Publicado: (2021)

COVID-19 vasculitis and novel vasculitis mimics
por: McGonagle, Dennis, et al.
Publicado: (2021)

Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades
por: Crossfield, Samantha S R, et al.
Publicado: (2021)

Harnessing Big Data, Smart and Digital Technologies and Artificial Intelligence for Preventing, Early Intercepting, Managing, and Treating Psoriatic Arthritis: Insights From a Systematic Review of the Literature
por: Bragazzi, Nicola Luigi, et al.
Publicado: (2022)

Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry
por: Michelena, Xabier, et al.
Publicado: (2022)

Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2
por: Marzo-Ortega, Helena, et al.
Publicado: (2017)

Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study
por: Marzo‐Ortega, H., et al.
Publicado: (2017)

Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis
por: Rudwaleit, M., et al.
Publicado: (2016)

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis
por: Kiltz, Uta, et al.
Publicado: (2020)

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages
por: Kiltz, U, et al.
Publicado: (2016)

Benefits of the use of blood conservation in scoliosis surgery
por: Loughenbury, Peter R, et al.
Publicado: (2016)

Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis
por: Li, Zhixiu, et al.
Publicado: (2021)

The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier
por: Macleod, Tom, et al.
Publicado: (2021)

Heterogeneity of axial spondyloarthritis: genetics, sex and structural damage matter
por: Li, Zhixiu, et al.
Publicado: (2022)

Recurrence of axial spondyloarthritis among first-degree relatives in a prospective 35-year-follow-up family study
por: van der Linden, Sjef M, et al.
Publicado: (2022)

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
por: van der Heijde, Désirée, et al.
Publicado: (2022)

Therapeutic implications of ongoing alveolar viral replication in COVID-19
por: McGonagle, Dennis, et al.
Publicado: (2022)

Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
por: van der Heijde, Désirée, et al.
Publicado: (2022)

Immune cartography of macrophage activation syndrome in the COVID-19 era
por: McGonagle, Dennis, et al.
Publicado: (2021)

New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function
por: Saviano, Anella, et al.
Publicado: (2023)

Time to move away from an oxygen-centric model of pulmonary infarction? – Authors' reply
por: McGonagle, Dennis, et al.
Publicado: (2021)

A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19
por: McGonagle, Dennis, et al.
Publicado: (2021)

Spinal Inflammation in the Absence of Sacroiliac Joint Inflammation on Magnetic Resonance Imaging in Patients With Active Nonradiographic Axial Spondyloarthritis
por: van der Heijde, Désirée, et al.
Publicado: (2014)

Interleukin-17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression
por: Menon, Bina, et al.
Publicado: (2014)

Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis
por: Belasco, Jennifer, et al.
Publicado: (2015)

Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis
por: Mease, Philip, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u6cis2lihs5epoepfksnoije7h